Safety of Upadacitinib in Immune-Mediated Inflammatory Diseases: Systematic Literature Review of Indirect and Direct Treatment Comparisons of Randomized Controlled Trials.
- DOI
- 10.1007/s12325-023-02732-6
- Published
- 2024-01-02
- Container
- Adv Ther
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s12325-023-02732-6,
title = {Safety of Upadacitinib in Immune-Mediated Inflammatory Diseases: Systematic Literature Review of Indirect and Direct Treatment Comparisons of Randomized Controlled Trials.},
author = {Mysler E and Burmester GR and Saffore CD and Liu J and Wegrzyn L and Yang C and Betts KA and Wang Y and Irvine AD and Panaccione R.},
year = {2024},
journal = {Adv Ther},
doi = {10.1007/s12325-023-02732-6},
url = {https://doi.org/10.1007/s12325-023-02732-6}
}RIS
TY - JOUR TI - Safety of Upadacitinib in Immune-Mediated Inflammatory Diseases: Systematic Literature Review of Indirect and Direct Treatment Comparisons of Randomized Controlled Trials. AU - Mysler E AU - Burmester GR AU - Saffore CD AU - Liu J AU - Wegrzyn L AU - Yang C AU - Betts KA AU - Wang Y AU - Irvine AD AU - Panaccione R. PY - 2024 JO - Adv Ther DO - 10.1007/s12325-023-02732-6 UR - https://doi.org/10.1007/s12325-023-02732-6 ER -
APA
E, M., GR, B., CD, S., J, L., L, W., C, Y., KA, B., Y, W., AD, I., & R., P. (2024). Safety of Upadacitinib in Immune-Mediated Inflammatory Diseases: Systematic Literature Review of Indirect and Direct Treatment Comparisons of Randomized Controlled Trials.. Adv Ther. https://doi.org/10.1007/s12325-023-02732-6
Source records
- europe-pmc · retrieved 2026-09-26T20:22:16.009Z